Ming Chou

Ming Chou is a seasoned finance professional with extensive experience in financial planning, analysis, and management within the pharmaceutical and investment sectors. Currently serving as a Senior Finance Manager at Eisai US, Ming oversees P&L management and forecasting for the oncology drug Halaven, manages the month-end close process, and develops annual business plans and budgets. Previous roles include Finance Manager at Eisai US, where budgeting for oncology marketing was a key responsibility, and Manager of Financial Planning & Analysis at Insmed Incorporated, focusing on process alignment and reporting. With a Master of Business Administration from Cornell Johnson Graduate School of Management and an academic background in Accounting and Biological Sciences, Ming demonstrates a strong analytical foundation coupled with leadership experience in managing finance teams and cross-functional collaboration.